Cargando…
Early postoperative tumor progression predicts clinical outcome in glioblastoma—implication for clinical trials
Molecular markers define the diagnosis of glioblastoma in the new WHO classification of 2016, challenging neuro-oncology centers to provide timely treatment initiation. The aim of this study was to determine whether a time delay to treatment initiation was accompanied by signs of early tumor progres...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378726/ https://www.ncbi.nlm.nih.gov/pubmed/28101701 http://dx.doi.org/10.1007/s11060-016-2362-z |